Skip to content
healthcare.dev

cough dm

NDC 17856-6312, dextromethorphan polistirex, suspension, from ATLANTIC BIOLOGICALS CORP..

Product NDC
17856-6312
Status
Listed
Labeler
ATLANTIC BIOLOGICALS CORP.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091135
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17856-6312 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN HYDROBROMIDE30 mg/5mL

Pharmacologic classes

Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
17856-6312-1178566312015 mL in 1 CUP (17856-6312-1)
17856-6312-21785663120210 mL in 1 CUP (17856-6312-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17856-6312 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17856-6312 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17856-6312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.